| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |